-
REAL-WORLD COMPARATIVE OUTCOMES AND COSTS OF SGLT-2 INHIBITORS VERSUS DPP-4 INHIBITORS IN TYPE 2 DIABETES PATIENTS WITH HEART FAILURE
Mar 18, 2026, 21:38 PM -
REAL-WORLD (RW) DISEASE PROGRESSION AND HEALTHCARE RESOURCE UTILIZATION (HCRU) AMONG PATIENTS WITH IGA NEPHROPATHY (IGAN) IN THE UNITED STATES (US)
Mar 18, 2026, 21:38 PM -
POSTURAL CORRECTION IN PRIMARY SCHOOL CHILDREN AND THE EFFECTS OF SCHOOL BACKPACKS ON POSTURE
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF CDK4/6 INHIBITORS FOR HR+/HER2- METASTATIC BREAST CANCER IN KAZAKHSTAN
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF CARDIOVASCULAR BENEFIT OF SEMAGLUTIDE VERSUS TIRZEPATIDE IN PATIENTS WITH OVERWEIGHT OR OBESITY IN CHINA
Mar 18, 2026, 21:38 PM -
ASSESSING THE ABILITY OF THE EQ-5D-5L TO CAPTURE LONG-TERM HEALTH-RELATED QUALITY OF LIFE IMPACTS OF HEREDITARY ANGIOEDEMA ATTACKS
Mar 18, 2026, 21:38 PM -
UNDERSTANDING DISEASE COMPLEXITY IN GRAVES’ DISEASE: A POPULATION-BASED NETWORK ANALYSIS OF COMORBIDITIES
Mar 18, 2026, 21:38 PM -
COMPARATIVEEFFECTIVENESS OF ANTIBIOTICS PLUS SUHUANG ZHIKE CAPSULES VERSUS ANTIBIOTICS ALONE FOR COUGH USING REAL-WORLD DATA
Mar 18, 2026, 21:38 PM -
COST-UTILITY MODEL OF MATERNAL RSV VACCINATION FROM THE PERSPECTIVE OF THE BRAZILIAN PUBLIC HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
PRODUCTIVITY LOSSES AFTER MISCARRIAGE: A PROSPECTIVE COHORT ANALYSIS USING THE IMTA PRODUCTIVITY COST QUESTIONNAIRE
Mar 18, 2026, 21:38 PM -
RELATIONSHIP BETWEEN IMPROVEMENT IN LUNG FUNCTION AND SYMPTOMS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH DUPILUMAB
Mar 18, 2026, 21:38 PM -
A LIFETIME COST-UTILITY ANALYSIS OF IGLARLIXI VERSUS IDEGASP IN TYPE 2 DIABETES IN TURKIYE
Mar 18, 2026, 21:38 PM -
DEFINING COUNTY LEVEL SOCIAL DETERMINANTS OF HEALTH BASED PHENOTYPES RELATED TO DEPRESSION IN THE UNITED STATES USING MACHINE LEARNING APPROACH
Mar 18, 2026, 21:38 PM -
COST-EFFICIENCY AND EXPANDED-ACCESS OF KIRSTY/MERILOG VS NOVOLOG IN DIABETES MELLITUS
Mar 18, 2026, 21:38 PM -
REAL-WORLD ONLINE CONVERSATIONS ON MASH/NASH: A ONE-YEAR SOCIAL MEDIA LISTENING ANALYSIS
Mar 18, 2026, 21:38 PM -
AI-ASSISTED GENERATION OF SYNTHETIC PATIENT-LEVEL DATA TO RECREATE WEIGHT-CHANGE OUTCOMES FROM THE STEP-4 SEMAGLUTIDE TRIAL
Mar 18, 2026, 21:38 PM -
INCIDENT INSOMNIA AND STRESS-RELATED MENTAL HEALTH OUTCOMES AFTER NUTRITIONAL SUPPLEMENT INITIATION IN ADULTS WITH TYPE 2 DIABETES: A MULTI-TIME-WINDOW COHORT STUDY USING THE TRINETX GLOBAL COLLABORATIVE NETWORK
Mar 18, 2026, 21:38 PM -
A REAL-WORLD RETROSPECTIVE COHORT STUDY CHARACTERIZING TREATMENT PATTERNS AMONG PATIENTS WITH LUPUS NEPHRITIS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
THE NUMBER NEEDED TO TREAT WITH DUPILUMAB TO PREVENT MODERATE OR SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS AND IMPROVE SYMPTOMS: BOREAS AND NOTUS POST HOC ANALYSIS
Mar 18, 2026, 21:38 PM -
REAL-WORLD CHARACTERISTICS AND TREATMENT PATTERNS OF PATIENTS TREATED WITH TALAZOPARIB + ENZALUTAMIDE FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN THE US COMMUNITY ONCOLOGY SETTING
Mar 18, 2026, 21:38 PM
